Market Closed -
OTC Markets
01:12:55 03/05/2024 am IST
5-day change
1st Jan Change
0.0001
USD
-50.00%
-50.00%
+9,900.00%
Sales 2020
281K
23.39M
Sales 2021
1.03M
85.88M
Capitalization
8.55M
712M
Net income 2020
-12M
-1B
Net income 2021
-10M
-834M
EV / Sales 2020
50.5
x
Net Debt
2020
1.2M
99.75M
Net Debt
2021
3.69M
307M
EV / Sales 2021
11.9
x P/E ratio 2020
-0.33
x
P/E ratio 2021
-0.62
x
Employees
7
Yield 2020 *
-
Yield 2021
-
Free-Float
100%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Marijuana Company of America, Inc. Accepts the Resignation of Director Edward Manolos from Board of Directors
05/23/05
CI
Marijuana Company of America, Inc. Announces Resignation of Tad Mailander as Independent Director
09/23/09
CI
Marijuana Company of America, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22/22/22
CI
Marijuana Company of America, Inc. Signs Master Agreement with Mitra-9 Suite of Alcohol Alternative Beverages Derived from the Natural Herbs Kava and Kratom
13/22/13
CI
Marijuana Company of America, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
23/22/23
CI
Marijuana Company of America Inc. Appoints Marco Guerrero to New Role as hempSMART Advisor Guerrero to Guide South American Distribution of hempSMART (TM) Products
12/22/12
CI
Marijuana Company of America, Inc. Announces Resignation of Marco Guerrero from the Board of Directors
09/22/09
CI
Marijuana Company of America, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
17/22/17
CI
Marijuana Company of America, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
16/22/16
CI
Marijuana Company of America, Inc. Auditor Raises 'Going Concern' Doubt
15/22/15
CI
Marijuana Company of America, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
17/21/17
CI
Marijuana Company of America, Inc. announced that it has received $2.880982 million in funding from St. George Investments, LLC
06/21/06
CI
Marijuana Company of America, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
20/21/20
CI
Marijuana Company of America, Inc. completed the acquisition of cDistro, LLC for $2.8 million.
26/21/26
CI
Marijuana Company of America, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
20/21/20
CI
More news
1 day -50.00%
1 week -50.00%
1 month -50.00%
3 months -50.00%
More quotes
Managers
Title Age Since
Chief Executive Officer
62
31/18/31
Sales & Marketing
-
-
Members of the board
Title Age Since
Chief Executive Officer
62
31/18/31
Director/Board Member
51
12/20/12
More insiders
Date
Price
Change
Volume
02/24/02
0.0001
-50.00%
22,809,641
01/24/01
0.0002
+33.33%
92,458,002
30/24/30
0.00015
+50.00%
64,879,849
29/24/29
0.0001
0.00%
7,515,564
26/24/26
0.0001
0.00%
25,613,347
Delayed Quote
OTC Markets, May 03, 2024 at 01:12 am IST
More quotes
Marijuana Company of America, Inc. is an owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its wholly owned subsidiary cDistro, Inc., it offers CBD brands along with smoke and vape shop-related products to wholesalers, c-stores, specialty retailers, and consumers in North America. Through its wholly owned subsidiary HSmart, Inc., it develops and sells CBD products under the brand name hempSMART. Its hempSMART wellness products offerings include hempSMART Brain, hempSMART Pain, hempSMART Pain Cream, hempSMART Drops, hempSMART Pet Drops, hempSMART Face, and hempSMART Drink Mix. hempSMART Brain is a personal care consumer product encapsulated with enriched non-psychoactive industrial hemp derived CBD. hempSMART Pain Cream each container is formulated with 300mg of non-psychoactive CBD.
More about the company
1st Jan change
Capi.
+9,900.00% 4.42M +29.68% 699B +25.07% 571B -4.35% 364B +17.65% 326B +3.77% 286B +14.68% 236B +4.71% 198B -12.43% 194B -3.79% 154B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1